Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1993-12-2
|
pubmed:abstractText |
Subconjunctival 5-fluorouracil has been an effective adjunct in glaucoma filtering surgery. We investigated the effectiveness of 5-fluorouracil in primary trabeculectomy combined with phacoemulsification and posterior chamber intraocular lens implantation (glaucoma triple procedure). Seventy-four patients were enrolled and randomly assigned into two groups to receive either no 5-fluorouracil (control patients) or low-dose 5-fluorouracil (mean total dose, 24.8 mg; mean number of injections, 5.0 +/- 1.3). The mean preoperative intraocular pressure was 20.1 +/- 5.4 mm Hg for the 5-fluorouracil group and 21.0 +/- 5.2 mm Hg for the control group (P = .48, Student's unpaired t-test). The mean number of medications was 2.2 +/- 1.0 and 2.0 +/- 1.0 (P = .49, Mann Whitney U test), respectively. At all postoperative visits, there were no statistically significant differences in mean intraocular pressures between the two groups. Mean follow-up was 13.2 months for 5-fluorouracil-treated patients and 15.0 months for control patients. At the last postoperative visit, mean intraocular pressures were 15.4 +/- 3.7 mm Hg and 15.0 +/- 5.0 mm Hg, respectively (P = .45, Student's unpaired t-test). Both groups showed comparable visual outcome (20/40 or better in 31 of 38 5-fluorouracil-treated patients [82%] vs 32 of 36 control patients [89%]) and a decrease in number of medications needed, 0.7 +/- 1.0 and 0.7 +/- 0.9, respectively (P = .96, Mann Whitney U test). Thus, 5-fluorouracil administered as in our study did not seem to have any effect in primary trabeculectomy combined with phacoemulsification and posterior chamber intraocular lens implantation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-9394
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
594-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8238220-Aged,
pubmed-meshheading:8238220-Cataract Extraction,
pubmed-meshheading:8238220-Chronic Disease,
pubmed-meshheading:8238220-Conjunctiva,
pubmed-meshheading:8238220-Fluorouracil,
pubmed-meshheading:8238220-Follow-Up Studies,
pubmed-meshheading:8238220-Glaucoma, Open-Angle,
pubmed-meshheading:8238220-Humans,
pubmed-meshheading:8238220-Injections,
pubmed-meshheading:8238220-Intraocular Pressure,
pubmed-meshheading:8238220-Lenses, Intraocular,
pubmed-meshheading:8238220-Prognosis,
pubmed-meshheading:8238220-Prospective Studies,
pubmed-meshheading:8238220-Trabeculectomy,
pubmed-meshheading:8238220-Visual Acuity
|
pubmed:year |
1993
|
pubmed:articleTitle |
Trabeculectomy, phacoemulsification, and posterior chamber lens implantation with and without 5-fluorouracil.
|
pubmed:affiliation |
Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan 48201.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|